Characteristics and Outcomes of Contacts of COVID-19 Patients Monitored Using an Automated Symptom Monitoring Tool - Maine, May-June 2020.
Identifieur interne : 000811 ( Main/Exploration ); précédent : 000810; suivant : 000812Characteristics and Outcomes of Contacts of COVID-19 Patients Monitored Using an Automated Symptom Monitoring Tool - Maine, May-June 2020.
Auteurs : Anna Krueger ; Jayleen K L. Gunn ; Joanna Watson ; Andrew E. Smith ; Rebecca Lincoln ; Sara L. Huston ; Emilio Dirlikov ; Sara RobinsonSource :
- MMWR. Morbidity and mortality weekly report [ 1545-861X ] ; 2020.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Automatisation (MeSH), Enfant (MeSH), Enfant d'âge préscolaire (MeSH), Femelle (MeSH), Humains (MeSH), Infections à coronavirus (diagnostic), Infections à coronavirus (prévention et contrôle), Infections à coronavirus (thérapie), Infections à coronavirus (épidémiologie), Jeune adulte (MeSH), Maine (épidémiologie), Mâle (MeSH), Nourrisson (MeSH), Nouveau-né (MeSH), Pandémies (prévention et contrôle), Pneumopathie virale (diagnostic), Pneumopathie virale (prévention et contrôle), Pneumopathie virale (thérapie), Pneumopathie virale (épidémiologie), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Surveillance épidémiologique (MeSH), Traçage des contacts (MeSH), Évaluation de programme (MeSH), Évaluation des symptômes (méthodes).
- MESH :
- diagnostic : Infections à coronavirus, Pneumopathie virale.
- méthodes : Évaluation des symptômes.
- prévention et contrôle : Infections à coronavirus, Pandémies, Pneumopathie virale.
- thérapie : Infections à coronavirus, Pneumopathie virale.
- épidémiologie : Infections à coronavirus, Maine, Pneumopathie virale.
- Adolescent, Adulte, Adulte d'âge moyen, Automatisation, Enfant, Enfant d'âge préscolaire, Femelle, Humains, Jeune adulte, Mâle, Nourrisson, Nouveau-né, Sujet âgé, Sujet âgé de 80 ans ou plus, Surveillance épidémiologique, Traçage des contacts, Évaluation de programme.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Automation (MeSH), Child (MeSH), Child, Preschool (MeSH), Contact Tracing (MeSH), Coronavirus Infections (diagnosis), Coronavirus Infections (epidemiology), Coronavirus Infections (prevention & control), Coronavirus Infections (therapy), Epidemiological Monitoring (MeSH), Female (MeSH), Humans (MeSH), Infant (MeSH), Infant, Newborn (MeSH), Maine (epidemiology), Male (MeSH), Middle Aged (MeSH), Pandemics (prevention & control), Pneumonia, Viral (diagnosis), Pneumonia, Viral (epidemiology), Pneumonia, Viral (prevention & control), Pneumonia, Viral (therapy), Program Evaluation (MeSH), Symptom Assessment (methods), Young Adult (MeSH).
- MESH :
- geographic , epidemiology : Maine.
- diagnosis : Coronavirus Infections, Pneumonia, Viral.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- methods : Symptom Assessment.
- prevention & control : Coronavirus Infections, Pandemics, Pneumonia, Viral.
- therapy : Coronavirus Infections, Pneumonia, Viral.
- Adolescent, Adult, Aged, Aged, 80 and over, Automation, Child, Child, Preschool, Contact Tracing, Epidemiological Monitoring, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Program Evaluation, Young Adult.
Abstract
SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is spread from person to person (1-3). Quarantine of exposed persons (contacts) for 14 days following their exposure reduces transmission (4-7). Contact tracing provides an opportunity to identify contacts, inform them of quarantine recommendations, and monitor their symptoms to promptly identify secondary COVID-19 cases (7,8). On March 12, 2020, Maine Center for Disease Control and Prevention (Maine CDC) identified the first case of COVID-19 in the state. Because of resource constraints, including staffing, Maine CDC could not consistently monitor contacts, and automated technological solutions for monitoring contacts were explored. On May 14, 2020, Maine CDC began enrolling contacts of patients with reported COVID-19 into Sara Alert (MITRE Corporation, 2020),* an automated, web-based, symptom monitoring tool. After initial communication with Maine CDC staff members, enrolled contacts automatically received daily symptom questionnaires via their choice of e-mailed weblink, text message, texted weblink, or telephone call until completion of their quarantine. Epidemiologic investigations were conducted for enrollees who reported symptoms or received a positive SARS-CoV-2 test result. During May 14-June 26, Maine CDC enrolled 1,622 contacts of 614 COVID-19 patients; 190 (11.7%) eventually developed COVID-19, highlighting the importance of identifying, quarantining, and monitoring contacts of COVID-19 patients to limit spread. In Maine, symptom monitoring was not feasible without the use of an automated symptom monitoring tool. Using a tool that permitted enrollees to specify a method of symptom monitoring was well received, because the majority of persons monitored (96.4%) agreed to report using this system.
DOI: 10.15585/mmwr.mm6931e2
PubMed: 32759918
PubMed Central: PMC7454893
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Characteristics and Outcomes of Contacts of COVID-19 Patients Monitored Using an Automated Symptom Monitoring Tool - Maine, May-June 2020.</title><author><name sortKey="Krueger, Anna" sort="Krueger, Anna" uniqKey="Krueger A" first="Anna" last="Krueger">Anna Krueger</name></author><author><name sortKey="Gunn, Jayleen K L" sort="Gunn, Jayleen K L" uniqKey="Gunn J" first="Jayleen K L" last="Gunn">Jayleen K L. Gunn</name></author><author><name sortKey="Watson, Joanna" sort="Watson, Joanna" uniqKey="Watson J" first="Joanna" last="Watson">Joanna Watson</name></author><author><name sortKey="Smith, Andrew E" sort="Smith, Andrew E" uniqKey="Smith A" first="Andrew E" last="Smith">Andrew E. Smith</name></author><author><name sortKey="Lincoln, Rebecca" sort="Lincoln, Rebecca" uniqKey="Lincoln R" first="Rebecca" last="Lincoln">Rebecca Lincoln</name></author><author><name sortKey="Huston, Sara L" sort="Huston, Sara L" uniqKey="Huston S" first="Sara L" last="Huston">Sara L. Huston</name></author><author><name sortKey="Dirlikov, Emilio" sort="Dirlikov, Emilio" uniqKey="Dirlikov E" first="Emilio" last="Dirlikov">Emilio Dirlikov</name></author><author><name sortKey="Robinson, Sara" sort="Robinson, Sara" uniqKey="Robinson S" first="Sara" last="Robinson">Sara Robinson</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32759918</idno><idno type="pmid">32759918</idno><idno type="doi">10.15585/mmwr.mm6931e2</idno><idno type="pmc">PMC7454893</idno><idno type="wicri:Area/Main/Corpus">000789</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000789</idno><idno type="wicri:Area/Main/Curation">000789</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000789</idno><idno type="wicri:Area/Main/Exploration">000789</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Characteristics and Outcomes of Contacts of COVID-19 Patients Monitored Using an Automated Symptom Monitoring Tool - Maine, May-June 2020.</title><author><name sortKey="Krueger, Anna" sort="Krueger, Anna" uniqKey="Krueger A" first="Anna" last="Krueger">Anna Krueger</name></author><author><name sortKey="Gunn, Jayleen K L" sort="Gunn, Jayleen K L" uniqKey="Gunn J" first="Jayleen K L" last="Gunn">Jayleen K L. Gunn</name></author><author><name sortKey="Watson, Joanna" sort="Watson, Joanna" uniqKey="Watson J" first="Joanna" last="Watson">Joanna Watson</name></author><author><name sortKey="Smith, Andrew E" sort="Smith, Andrew E" uniqKey="Smith A" first="Andrew E" last="Smith">Andrew E. Smith</name></author><author><name sortKey="Lincoln, Rebecca" sort="Lincoln, Rebecca" uniqKey="Lincoln R" first="Rebecca" last="Lincoln">Rebecca Lincoln</name></author><author><name sortKey="Huston, Sara L" sort="Huston, Sara L" uniqKey="Huston S" first="Sara L" last="Huston">Sara L. Huston</name></author><author><name sortKey="Dirlikov, Emilio" sort="Dirlikov, Emilio" uniqKey="Dirlikov E" first="Emilio" last="Dirlikov">Emilio Dirlikov</name></author><author><name sortKey="Robinson, Sara" sort="Robinson, Sara" uniqKey="Robinson S" first="Sara" last="Robinson">Sara Robinson</name></author></analytic><series><title level="j">MMWR. Morbidity and mortality weekly report</title><idno type="eISSN">1545-861X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Aged, 80 and over (MeSH)</term><term>Automation (MeSH)</term><term>Child (MeSH)</term><term>Child, Preschool (MeSH)</term><term>Contact Tracing (MeSH)</term><term>Coronavirus Infections (diagnosis)</term><term>Coronavirus Infections (epidemiology)</term><term>Coronavirus Infections (prevention & control)</term><term>Coronavirus Infections (therapy)</term><term>Epidemiological Monitoring (MeSH)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Infant (MeSH)</term><term>Infant, Newborn (MeSH)</term><term>Maine (epidemiology)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Pandemics (prevention & control)</term><term>Pneumonia, Viral (diagnosis)</term><term>Pneumonia, Viral (epidemiology)</term><term>Pneumonia, Viral (prevention & control)</term><term>Pneumonia, Viral (therapy)</term><term>Program Evaluation (MeSH)</term><term>Symptom Assessment (methods)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Automatisation (MeSH)</term><term>Enfant (MeSH)</term><term>Enfant d'âge préscolaire (MeSH)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (diagnostic)</term><term>Infections à coronavirus (prévention et contrôle)</term><term>Infections à coronavirus (thérapie)</term><term>Infections à coronavirus (épidémiologie)</term><term>Jeune adulte (MeSH)</term><term>Maine (épidémiologie)</term><term>Mâle (MeSH)</term><term>Nourrisson (MeSH)</term><term>Nouveau-né (MeSH)</term><term>Pandémies (prévention et contrôle)</term><term>Pneumopathie virale (diagnostic)</term><term>Pneumopathie virale (prévention et contrôle)</term><term>Pneumopathie virale (thérapie)</term><term>Pneumopathie virale (épidémiologie)</term><term>Sujet âgé (MeSH)</term><term>Sujet âgé de 80 ans ou plus (MeSH)</term><term>Surveillance épidémiologique (MeSH)</term><term>Traçage des contacts (MeSH)</term><term>Évaluation de programme (MeSH)</term><term>Évaluation des symptômes (méthodes)</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Maine</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Symptom Assessment</term></keywords><keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Évaluation des symptômes</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term><term>Pandemics</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Infections à coronavirus</term><term>Pandémies</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Maine</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Automation</term><term>Child</term><term>Child, Preschool</term><term>Contact Tracing</term><term>Epidemiological Monitoring</term><term>Female</term><term>Humans</term><term>Infant</term><term>Infant, Newborn</term><term>Male</term><term>Middle Aged</term><term>Program Evaluation</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Automatisation</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Nourrisson</term><term>Nouveau-né</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Surveillance épidémiologique</term><term>Traçage des contacts</term><term>Évaluation de programme</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is spread from person to person (1-3). Quarantine of exposed persons (contacts) for 14 days following their exposure reduces transmission (4-7). Contact tracing provides an opportunity to identify contacts, inform them of quarantine recommendations, and monitor their symptoms to promptly identify secondary COVID-19 cases (7,8). On March 12, 2020, Maine Center for Disease Control and Prevention (Maine CDC) identified the first case of COVID-19 in the state. Because of resource constraints, including staffing, Maine CDC could not consistently monitor contacts, and automated technological solutions for monitoring contacts were explored. On May 14, 2020, Maine CDC began enrolling contacts of patients with reported COVID-19 into Sara Alert (MITRE Corporation, 2020),* an automated, web-based, symptom monitoring tool. After initial communication with Maine CDC staff members, enrolled contacts automatically received daily symptom questionnaires via their choice of e-mailed weblink, text message, texted weblink, or telephone call until completion of their quarantine. Epidemiologic investigations were conducted for enrollees who reported symptoms or received a positive SARS-CoV-2 test result. During May 14-June 26, Maine CDC enrolled 1,622 contacts of 614 COVID-19 patients; 190 (11.7%) eventually developed COVID-19, highlighting the importance of identifying, quarantining, and monitoring contacts of COVID-19 patients to limit spread. In Maine, symptom monitoring was not feasible without the use of an automated symptom monitoring tool. Using a tool that permitted enrollees to specify a method of symptom monitoring was well received, because the majority of persons monitored (96.4%) agreed to report using this system.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32759918</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1545-861X</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>31</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>07</Day></PubDate></JournalIssue><Title>MMWR. Morbidity and mortality weekly report</Title><ISOAbbreviation>MMWR Morb Mortal Wkly Rep</ISOAbbreviation></Journal><ArticleTitle>Characteristics and Outcomes of Contacts of COVID-19 Patients Monitored Using an Automated Symptom Monitoring Tool - Maine, May-June 2020.</ArticleTitle><Pagination><MedlinePgn>1026-1030</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.15585/mmwr.mm6931e2</ELocationID><Abstract><AbstractText>SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is spread from person to person (1-3). Quarantine of exposed persons (contacts) for 14 days following their exposure reduces transmission (4-7). Contact tracing provides an opportunity to identify contacts, inform them of quarantine recommendations, and monitor their symptoms to promptly identify secondary COVID-19 cases (7,8). On March 12, 2020, Maine Center for Disease Control and Prevention (Maine CDC) identified the first case of COVID-19 in the state. Because of resource constraints, including staffing, Maine CDC could not consistently monitor contacts, and automated technological solutions for monitoring contacts were explored. On May 14, 2020, Maine CDC began enrolling contacts of patients with reported COVID-19 into Sara Alert (MITRE Corporation, 2020),* an automated, web-based, symptom monitoring tool. After initial communication with Maine CDC staff members, enrolled contacts automatically received daily symptom questionnaires via their choice of e-mailed weblink, text message, texted weblink, or telephone call until completion of their quarantine. Epidemiologic investigations were conducted for enrollees who reported symptoms or received a positive SARS-CoV-2 test result. During May 14-June 26, Maine CDC enrolled 1,622 contacts of 614 COVID-19 patients; 190 (11.7%) eventually developed COVID-19, highlighting the importance of identifying, quarantining, and monitoring contacts of COVID-19 patients to limit spread. In Maine, symptom monitoring was not feasible without the use of an automated symptom monitoring tool. Using a tool that permitted enrollees to specify a method of symptom monitoring was well received, because the majority of persons monitored (96.4%) agreed to report using this system.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Krueger</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Gunn</LastName><ForeName>Jayleen K L</ForeName><Initials>JKL</Initials></Author><Author ValidYN="Y"><LastName>Watson</LastName><ForeName>Joanna</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials></Author><Author ValidYN="Y"><LastName>Lincoln</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Huston</LastName><ForeName>Sara L</ForeName><Initials>SL</Initials></Author><Author ValidYN="Y"><LastName>Dirlikov</LastName><ForeName>Emilio</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>MMWR Morb Mortal Wkly Rep</MedlineTA><NlmUniqueID>7802429</NlmUniqueID><ISSNLinking>0149-2195</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001331" MajorTopicYN="N">Automation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016358" MajorTopicYN="Y">Contact Tracing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062665" MajorTopicYN="Y">Epidemiological Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008281" MajorTopicYN="N" Type="Geographic">Maine</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015397" MajorTopicYN="N">Program Evaluation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063189" MajorTopicYN="N">Symptom Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32759918</ArticleId><ArticleId IdType="doi">10.15585/mmwr.mm6931e2</ArticleId><ArticleId IdType="pmc">PMC7454893</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Euro Surveill. 2020 Jun;25(23):</Citation><ArticleIdList><ArticleId IdType="pubmed">32553064</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Glob Health. 2020 Apr;8(4):e488-e496</Citation><ArticleIdList><ArticleId IdType="pubmed">32119825</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2020 Jun;95:288-293</Citation><ArticleIdList><ArticleId IdType="pubmed">32171948</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2020 May 5;172(9):577-582</Citation><ArticleIdList><ArticleId IdType="pubmed">32150748</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):411-415</Citation><ArticleIdList><ArticleId IdType="pubmed">32271722</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2020 Jul 03;69(26):830-835</Citation><ArticleIdList><ArticleId IdType="pubmed">32614814</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):377-381</Citation><ArticleIdList><ArticleId IdType="pubmed">32240128</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2020 Jun;92(6):639-644</Citation><ArticleIdList><ArticleId IdType="pubmed">32141619</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Dirlikov, Emilio" sort="Dirlikov, Emilio" uniqKey="Dirlikov E" first="Emilio" last="Dirlikov">Emilio Dirlikov</name><name sortKey="Gunn, Jayleen K L" sort="Gunn, Jayleen K L" uniqKey="Gunn J" first="Jayleen K L" last="Gunn">Jayleen K L. Gunn</name><name sortKey="Huston, Sara L" sort="Huston, Sara L" uniqKey="Huston S" first="Sara L" last="Huston">Sara L. Huston</name><name sortKey="Krueger, Anna" sort="Krueger, Anna" uniqKey="Krueger A" first="Anna" last="Krueger">Anna Krueger</name><name sortKey="Lincoln, Rebecca" sort="Lincoln, Rebecca" uniqKey="Lincoln R" first="Rebecca" last="Lincoln">Rebecca Lincoln</name><name sortKey="Robinson, Sara" sort="Robinson, Sara" uniqKey="Robinson S" first="Sara" last="Robinson">Sara Robinson</name><name sortKey="Smith, Andrew E" sort="Smith, Andrew E" uniqKey="Smith A" first="Andrew E" last="Smith">Andrew E. Smith</name><name sortKey="Watson, Joanna" sort="Watson, Joanna" uniqKey="Watson J" first="Joanna" last="Watson">Joanna Watson</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000811 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000811 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidSeniorV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32759918
|texte= Characteristics and Outcomes of Contacts of COVID-19 Patients Monitored Using an Automated Symptom Monitoring Tool - Maine, May-June 2020.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32759918" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidSeniorV1
| This area was generated with Dilib version V0.6.37. |  |